| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 11/24/2005 | US20050261212 RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNA |
| 11/24/2005 | US20050261187 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy |
| 11/24/2005 | US20050261186 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/24/2005 | US20050261184 Method for treating glaucoma |
| 11/24/2005 | US20050261183 PTHrP-derived modulators of smooth muscle proliferation |
| 11/24/2005 | US20050261170 Folate conjugates and complexes |
| 11/24/2005 | US20050260767 Treatment with cytokines |
| 11/24/2005 | US20050260757 Novel reagents for intracellular delivery of macromolecules |
| 11/24/2005 | US20050260756 Complex for facilitating delivery of dsRNA into a cell and uses thereof |
| 11/24/2005 | US20050260755 Sequential delivery of oligomeric compounds |
| 11/24/2005 | US20050260747 Embryonic stem cells and neural progenitor cells derived therefrom |
| 11/24/2005 | US20050260734 Packaging cells |
| 11/24/2005 | US20050260726 Novel human protease inhibitor and polynucleotides encoding the same |
| 11/24/2005 | US20050260717 Double transdominant fusion gene and protein |
| 11/24/2005 | US20050260709 Lipin1 function |
| 11/24/2005 | US20050260670 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 11/24/2005 | US20050260629 Differential drug sensitivity |
| 11/24/2005 | US20050260620 Hearing loss, deafness, tinnitus, motion and balance disorders, cancer and proliferative diseases |
| 11/24/2005 | US20050260617 Oligo-or polynucleotides |
| 11/24/2005 | US20050260616 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 11/24/2005 | US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof |
| 11/24/2005 | US20050260596 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 11/24/2005 | US20050260579 TGF-beta type receptor cDNAs encoded products |
| 11/24/2005 | US20050260578 Antisense modulation of cellular apoptosis susceptibity gene expression |
| 11/24/2005 | US20050260576 Recombinantly expressed and isolated human SCN1A polypeptide and a modified human SCN1A nucleic acid that encodes it; producing an antibody that specifically binds a sodium channel; detecting and/or identifying a sodium channel polypeptide; anticonvulsants, neuroprotective agents and analgesics |
| 11/24/2005 | US20050260564 Non-cytotoxic oriP replicon |
| 11/24/2005 | US20050260276 Methods and articles for the delivery of therapeutic agents |
| 11/24/2005 | US20050260271 Composition comprising layered host material with intercalated functional-active organic compound |
| 11/24/2005 | US20050260270 Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo |
| 11/24/2005 | US20050260261 Neutral-cationic lipid for nucleic acid and drug delivery |
| 11/24/2005 | US20050260224 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 11/24/2005 | US20050260223 Salmonella vaccine materials and methods |
| 11/24/2005 | US20050260216 Polypeptide containing a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 11/24/2005 | US20050260214 Composition and method for introduction of RNA interference sequences into targeted cells and tissues |
| 11/24/2005 | US20050260209 Ephrin-b receptor protein involved in carcinoma |
| 11/24/2005 | US20050260202 Methods for producing proliferating muscle cells |
| 11/24/2005 | US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents |
| 11/24/2005 | US20050260188 Cross-linked gels of chemically activated carboxypolysaccharides and polyalkylene oxides |
| 11/24/2005 | US20050260185 Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase |
| 11/24/2005 | US20050260180 Materials and methods for treating vascular leakage in the eye |
| 11/24/2005 | US20050260179 Stem and progenitor cell capture for tissue regeneration |
| 11/24/2005 | US20050260176 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 11/24/2005 | US20050260168 Compositions comprising viruses and methods for concentrating virus preparations |
| 11/24/2005 | US20050260167 Suppressing growth of pancreatic tumors or cancer cells having a K-ras gene point mutation by administering directly to the tumor cells an adenoviral vector having a DNA sequence encoding human interferon alpha and linked to a promoter and an antisense K-ras expressing vector |
| 11/24/2005 | US20050260166 Expressional enhancers from viruses |
| 11/24/2005 | US20050260165 HS-40 enhancer-containing vector |
| 11/24/2005 | US20050260164 Gene regulation with aptamer and modulator complexes for gene therapy |
| 11/24/2005 | US20050260163 Triplex hairpin ribozyme |
| 11/24/2005 | US20050260162 Conditionally replicative adenovirus to target the Rb and Rb-related pathways |
| 11/24/2005 | US20050260161 Method for modulating, regulating and/or stabilizing angiogenesis |
| 11/24/2005 | US20050260160 use of gene therapy in the treatment of aseptic loosening of orthopaedic prostheses; adenoviral vectors and prodrugs are used for simultaneous, separate or sequential destruction of interface tissue allowing subsequent recementing of loose prostheses in a minimally invasive manner |
| 11/24/2005 | US20050260159 contacting a collagenase-producing cell in a tissue with an intracellular IL-1 receptor antagonist peptide to inhibit tissue destruction, thus inhibiting inflammatory diseses e.g. rheumatoid arthritis, degenerative intervertebral disc disease and chronic skin ulcers; inhibitor of matrix metalloproteinase |
| 11/24/2005 | US20050260158 Human stem cell materials and methods |
| 11/24/2005 | US20050260157 Method and agent for treating vulnerable plaque |
| 11/24/2005 | US20050260156 Modified vaccinia virus ankara for the vaccination of neonates |
| 11/24/2005 | US20050259281 Method, apparatus and computer program for transforming digital colour images |
| 11/24/2005 | CA2820168A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2566883A1 Methods and kits to detect hereditary angioedema type iii |
| 11/24/2005 | CA2566721A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 11/24/2005 | CA2565424A1 Macromolecule-containing sustained release intraocular implants and related methods |
| 11/24/2005 | CA2565070A1 Anti-ctgf agents for the treatment of pancreatic cancer |
| 11/24/2005 | CA2564934A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 11/24/2005 | CA2564126A1 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 11/24/2005 | CA2563671A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2563396A1 Method of using adenoviral vectors to induce an immune response |
| 11/24/2005 | CA2563311A1 Inducible dimerization of growth factor receptors for treating cancer |
| 11/24/2005 | CA2562788A1 Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences |
| 11/24/2005 | CA2562283A1 Methods, compositions, and preparations for delivery of immune response modifiers |
| 11/24/2005 | CA2508065A1 Antiproliferative drug and delivery device |
| 11/23/2005 | EP1598671A1 Diagnosis and therapy of cancer using SGP28-related molecules |
| 11/23/2005 | EP1598425A1 Modified Vaccinia Ankara virus variant |
| 11/23/2005 | EP1598420A2 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 11/23/2005 | EP1598362A2 Chlamidya trachomatis antigens |
| 11/23/2005 | EP1597587A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 11/23/2005 | EP1597378A2 Production of multimeric proteins |
| 11/23/2005 | EP1597377A2 Method of using adenoviral vectors with increased persistence in vivo |
| 11/23/2005 | EP1597355A2 Method and materials relating to neurogenesis |
| 11/23/2005 | EP1597354A2 System for external control of oncolytic virus replication |
| 11/23/2005 | EP1596834A2 Microparticles comprising polynucleotides adsorbed on the surface of or entrapped within the microparticles |
| 11/23/2005 | EP1596811A2 Compositions and methods to modulate immune and inflammatory responses |
| 11/23/2005 | EP1596806A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 11/23/2005 | EP1513558A4 METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1alpha |
| 11/23/2005 | EP1444347B1 METHOD FOR THE IN VITRO SYNTHESIS OF SHORT DOUBLE STRANDED RNAs |
| 11/23/2005 | EP1383872B1 Genetically modified yt cell line and use thereof |
| 11/23/2005 | EP1226264B1 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 11/23/2005 | EP1185628B1 Isolation of a human retrovirus |
| 11/23/2005 | EP1183034B1 Modulators of methylation for control of bacterial virulence |
| 11/23/2005 | EP1117767B1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 11/23/2005 | EP0958357B1 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 11/23/2005 | EP0929311B1 INHIBITION OF APOPTOSIS USING INTERLEUKIN-1 beta-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS |
| 11/23/2005 | EP0837939B1 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 11/23/2005 | EP0781344B1 Novel implant and novel vector for the treatment of acquired diseases |
| 11/23/2005 | EP0770129B1 Zinc finger protein derivatives and methods therefor |
| 11/23/2005 | EP0662128B1 Methods and compositions for controlling translation of hcv proteins |
| 11/23/2005 | CN1701121A Improved transfection of eukaryontic cells with linear polynucleotides by electroporation |
| 11/23/2005 | CN1701077A Use of antisense oligonucleotides to inhibit the expression of Akt-1 |
| 11/23/2005 | CN1699410A Apolipoprotein A-1 agonists and their use to treat dyslipidemic disorders |
| 11/23/2005 | CN1698904A Method for inhibiting immunologic rejection of human heterogeneic organ transplantation |
| 11/23/2005 | CN1228088C Cross-breed vaccine carrier and its application |
| 11/23/2005 | CN1228041C Methods for preparation of lipid-encapsulated therapeutic agents |